- Home
- KGEI vs QSI Comparison
KGEI vs QSI Comparison
Compare KGEI & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KGEI | QSI |
|---|---|---|
| Founded | 2008 | 2013 |
| Country | United States | United States |
| Employees | N/A | 145 |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 191.0M | 194.8M |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | KGEI | QSI |
|---|---|---|
| Price | $5.36 | $0.95 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $1.00 |
| AVG Volume (30 Days) | 219.9K | ★ 6.3M |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $32.37 | N/A |
| Revenue Next Year | $4.72 | $618.07 |
| P/E Ratio | $7.94 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.35 | $0.69 |
| 52 Week High | $8.27 | $3.10 |
Technical Indicators
Market Signals| Indicator | KGEI | QSI |
|---|---|---|
| Relative Strength Index (RSI) | 47.56 | 43.12 |
| Support Level | $5.07 | $0.87 |
| Resistance Level | $5.88 | $1.08 |
| Average True Range (ATR) | 0.30 | 0.11 |
| MACD | -0.03 | -0.03 |
| Stochastic Oscillator | 42.61 | 7.04 |
Price Performance
Historical ComparisonAbout KGEI Kolibri Global Energy Inc.
Kolibri Global Energy Inc is a North American energy company focused on finding and exploiting energy projects in oil, gas, and clean and sustainable energy. It is focused on the acquisition, exploration, and production of oil and gas reserves. The company owns and operates shale oil and gas properties in the United States. The company derives a majority of its revenue from the United States.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on proteomics research and analytical technologies. It develops single-molecule detection platforms designed to enable next-generation protein sequencing (NGPS) and large-scale protein analysis. Its technology supports massively parallel sequencing of proteins and can also be applied to the study of nucleic acids, providing tools for researchers and clinical applications in molecular analysis. The company's revenue is derived from sales of products and services.